Michael Shapiro

Associate Professor

  • 6602 Citations
  • 26 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michael Shapiro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies

Mahmood, T., Minnier, J., Ito, M. K., Li, Q. H., Koren, A., Kam, I. W., Fazio, S. & Shapiro, M., Jan 1 2020, (Accepted/In press) In : European journal of preventive cardiology.

Research output: Contribution to journalArticle

Open Access
  • 1 Scopus citations

    Application of PCSK9 Inhibitors in Practice: Part 2: The Patient Experience

    Kaufman, T. M., Warden, B. A., Minnier, J., Miles, J. R., Duell, P. B., Purnell, J. Q., Wojcik, C., Fazio, S. & Shapiro, M. D., Jan 4 2019, In : Circulation research. 124, 1, p. 32-37 6 p.

    Research output: Contribution to journalArticle

  • 16 Scopus citations

    Brief commentary: Marijuana and cardiovascular disease—what should we tell patients?

    Kaufman, T., Fazio, S. & Shapiro, M., Jan 15 2019, In : Annals of Internal Medicine. 170, 2, p. 119-120 2 p.

    Research output: Contribution to journalComment/debate

    2 Scopus citations

    Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy

    Warden, B. A., Minnier, J., Watts, G. F., Fazio, S. & Shapiro, M. D., Jul 1 2019, In : Journal of clinical lipidology. 13, 4, p. 580-585 6 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations
    Open Access
  • 7 Scopus citations